CLL Academy – Management of CLL in real life – Thursday, February 26, 2026 Uncategorized / Sharon Rawet Lederer Open to access this content CLL Academy – Management of CLL in real life – Thursday, February 26, 2026 Read More »
Multiple Myeloma Academy – Journal Club – Daratumumab‐based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study – Monday, February 23, 2026 Uncategorized / Sharon Rawet Lederer Open to access this content Multiple Myeloma Academy – Journal Club – Daratumumab‐based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study – Monday, February 23, 2026 Read More »
New medicine approved to treat Chronic Graft-Versus-Host Disease – Wednesday, February 18, 2026 Uncategorized / Sharon Rawet Lederer Open to access this content New medicine approved to treat Chronic Graft-Versus-Host Disease – Wednesday, February 18, 2026 Read More »
IACH Annual Meeting 2026 Scientific Program course – October 15-17, 2026 – Live Broadcast CME credits / Sharon Rawet Lederer Open to access this content IACH Annual Meeting 2026 Scientific Program course – October 15-17, 2026 – Live Broadcast Read More »
Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma – Monday, June 16, 2025 Uncategorized / Sharon Rawet Lederer Open to access this content Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma – Monday, June 16, 2025 Read More »
Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain Amyloidosis – Tuesday, October 14, 2025 Uncategorized / Sharon Rawet Lederer Open to access this content Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain Amyloidosis – Tuesday, October 14, 2025 Read More »
Using Mass Spectrometry Assays in Multiple Myeloma: Where Do We Stand? – Tuesday, April 22, 2025 Uncategorized / Sharon Rawet Lederer Open to access this content Using Mass Spectrometry Assays in Multiple Myeloma: Where Do We Stand? – Tuesday, April 22, 2025 Read More »
Highlights from IMS 2025: A Focus on CELMoDs – Monday, October 20, 2025 Uncategorized / Sharon Rawet Lederer Open to access this content Highlights from IMS 2025: A Focus on CELMoDs – Monday, October 20, 2025 Read More »
Characterization of clonal dynamics using duplex sequencing in donor-recipient pairs decades after hematopoietic cell transplantation – Tuesday, January 21, 2025 Uncategorized / Sharon Rawet Lederer Open to access this content Characterization of clonal dynamics using duplex sequencing in donor-recipient pairs decades after hematopoietic cell transplantation – Tuesday, January 21, 2025 Read More »
CMV recommendations ECIL-10 – Thursday, June 26, 2025 Uncategorized / Sharon Rawet Lederer Open to access this content CMV recommendations ECIL-10 – Thursday, June 26, 2025 Read More »
